ENGOT-ov24-NSGO/AVANOVA
Study documentation (link to documents, only accessible with password to www.nsgo.org). Click HERE for access.
|
Sponsor |
NSGO-CTU |
|
NSGO-CTU Project Manager |
Nicole Buchner Vinum NSGO-CTU, Rigshospitalet, Copenhagen, Denmark nicole.buchner.vinum@regionh.dk +45 3545 3311 |
|
Study Chair |
Mansoor Raza Mirza NSGO-CTU, Rigshospitalet, Copenhagen, Denmark +45 3545 9624 |
|
Drugs |
Niraparib and Bevacizumab |
|
Phase |
II |
|
Randomized trial |
Yes |
|
Type |
Open-label |
|
Total number of patients |
94 patients required |
|
Number of patients recruited |
Recruitment statistics – link |
|
Trial status |
Recruitment closed |
|
Date of first site activated |
02.03.2016 |
|
eCRF |
Open Clinica Test – link (protected information – access only with login) Open Clinica Live – link (protected information – access only with login) |
|
Site List |
Site List – link (protected information – access only with login) |
|
Protocol summary |
ClinicalTrials.gov – link |